Transaldolase (TALDO) deficiency is a newly recognized metabolic disease, which has been reported so far in 2 patients presenting with liver failure and cirrhosis. This evidence concerns the gene TALDO1 and hyperinsulinemic hypoglycemia, familial, 4.